GlassScriptPhysician profile
Christina Gray
NPI 1659392173
$13,419.97
in general payments reported to CMS, 2019-2025
37 companies · $2,884 in 2025
The $2,884 reported for 2025 was more than what 96% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,849 · 2022: $1,942 · 2023: $2,756 · 2024: $2,989 · 2025: $2,884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,629.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,871.74 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $1,575.07 | 2021-2025 | |
| Novo Nordisk INC | $1,270.42 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,184.15 | 2021-2025 | |
| Glaxosmithkline, LLC. | $1,164.70 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Lilly USA, LLC | $1,144.35 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Edwards Lifesciences Corporation | $751.21 | 2021-2024 | Pascal, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Bayer Healthcare Pharmaceuticals INC. | $622.72 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $575.39 | 2021-2025 | Jardiance, Synjardy, Spiriva Respimat |
| Amgen INC. | $564.69 | 2021-2025 | Repatha, Otezla, Otezla |
| Boston Scientific Corporation | $321.47 | 2021-2025 | Watchman Flx, Emerge Push, Watchman |
| Exact Sciences Corporation | $292.73 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Phathom Pharmaceuticals, INC. | $269.75 | 2024-2025 | Voquezna |
| Biosense Webster, INC. | $268.71 | 2023-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $228.74 | 2025 | Caplyta |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christina Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.